HomeACADEMIA
ACADEMIA

Osteoporosis Experts Express “Shock” at Discontinuation of Development of Odanacatib
(Oct.7.2016)

Experts of osteoporosis treatments lamented the discontinuation of development of odanacatib, which was expected to be safer and more effective than existing drugs, at the annual meeting of the Japan Osteoporosis Society (JOS) ...
(LOG IN FOR FULL STORY)

News Calendar